ArticlePharmaceutics2024

Early-Stage IM Treatment with the Host-Derived Immunostimulant CPDI-02 Increases Curative Protection of Healthy Outbred Mice Against Subcutaneous Infection with Community-Acquired Methicillin-Resistant

Jason P Stewart et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.